Improving Schizophrenia Treatment Outcomes with Long-Acting Injectables: A Focus on Effective Patient Counseling
This webinar will address the place of long acting injectables in schizophrenia treatment, currently available agents, and the effective patient counseling techniques pharmacists can employ to improve patient outcomes.
An Individualized Approach to Major Depressive Disorder: The Pharmacist's Role
This activity reviews how to differentiate and treat MDD with newly incorporated “specifiers” that contribute to a more complex clinical presentation and course of illness.
Examining Major Depressive Disorder: Emerging Therapies and the Potential Beyond Monoaminergic Pathways
An estimated that 16.2 million Americans have had one major depressive episode in 2016. This educational activity aims to examine the neurobiology of major depressive orders.
Major Depressive Disorder and Management of Population Health
This activity examines the prevalence of major depressive disorder and the diversity of treatment options.